The relationship between CYP7A1 polymorphisms, coronary artery disease & serum lipid markers

Area of Science:

• Genetics
• Cardiovascular Disease
• Biochemistry

Background:

• Polymorphic variants of the Cholesterol 7 alpha-hydroxylase (CYP7A1) gene are implicated in atherosclerosis-based coronary artery disease (CAD) risk.
• CYP7A1 plays a crucial role in cholesterol metabolism and bile acid synthesis, influencing serum lipid profiles.

Purpose of the Study:

• To investigate the association between CYP7A1 gene polymorphisms and the risk of coronary artery disease (CAD) in a Caucasian population.
• To determine if specific CYP7A1 variants correlate with CAD symptoms, risk factors, and serum lipid levels.

Main Methods:

• Haplotype-tagging single nucleotide polymorphisms (SNPs) of the CYP7A1 gene were analyzed.
• The study population comprised individuals from the Caucasian ethnic group.
• Statistical analyses were performed to assess associations with CAD, its clinical manifestations, and lipid profiles.

Main Results:

• No significant association was found between CYP7A1 genetic variants and an increased risk of developing CAD.
• The common rs3808607 variant of CYP7A1 was associated with altered concentrations of serum total cholesterol and low-density lipoprotein (LDL) cholesterol.
• The C allele and CC genotype of the rs11786580 polymorphism were more prevalent in patients experiencing myocardial infarction, with a stronger association observed when stratified by sex.

Conclusions:

• CYP7A1 gene variants are not directly associated with an elevated risk of coronary artery disease (CAD) in the studied Caucasian population.
• Specific CYP7A1 polymorphisms, namely rs3808607 and rs11786580, show potential as biomarkers for modified lipid profiles and myocardial infarction risk, respectively.
• The rs11786580 polymorphism's association with myocardial infarction risk is particularly pronounced in males, suggesting a sex-specific genetic influence on cardiovascular events.